Methotrexate Treatment for Ectopic Pregnancy

Status Completed

Clinical Trial Summary

Ectopic pregnancy is an important cause of maternal morbidity and occasionally mortality. Deaths associated with ectopic pregnancy have declined, though approximately 75% of deaths in the first trimester and 9-13% of all pregnancy-related deaths are associated ectopic pregnancy. The main stays of management for ectopic pregnancy were surgery and medical treatment. Medical management with systemic methotrexate administration avoids the inherent morbidity of anesthesia and surgery is cost-effective, and also offers success rates comparable to surgical management, with no loss in future potential fertility.

However, although medical management using methotrexate is used commonly, there is no solid consensus regarding dose protocol. Currently, there are three methotrexate protocols for the treatment of an ectopic pregnancy, "multi-dose", "single-dose", or "two-dose". Among them, the multi-dose protocol includes the administration of 4 methotrexate doses alternating with leucovorin (rescue regimen). As a result of the multiple dosing of methotrexate, side effects are more common. In contrast, the advantages of the single-dose protocol include elimination of a rescue regimen, lower incidence of adverse effects, and better compliance. However, the single-dose protocol was found to be associated with a considerably lower success rate as compared with the multi-dose protocol (88% versus 93%) in a recent meta-analysis. The two-dose protocol, which it balances efficacy and safety/convenience, was described as a cross between the multi-dose and single-dose protocols.

However, there were a few studies comparing between single-dose and two-dose protocol. The purpose of this prospective randomized trial was to compared the success rates of single-dose and two-dose methotrexate protocol for the treatment of tubal ectopic pregnancy.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01855568
Study type	Interventional
Source	CHA University
Contact
Status	Completed
Phase	Phase 3
Start date	May 2013
Completion date	April 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02995356` - Evaluation of the Axonemal Dynein Heavy Chain 5 and Creatine Kinase Concentration in Cervical Fluid for Early Detection of the Ectopic Pregnancy
Completed	`NCT01876004` - Effectiveness Of Expectant Management In The Tubal Ectopic Pregnancy	Phase 4
Not yet recruiting	`NCT05039853` - Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task	N/A
Completed	`NCT00194207` - Risk Factors of Ectopic Pregnancy	N/A
Completed	`NCT00827970` - Randomized Population-Based Study on Chlamydia Trachomatis Screening	N/A
Recruiting	`NCT05374720` - Analysis of the Molecular Composition of Tubal Cilia in Patients With or Without Ectopic Pregnancy	N/A
Completed	`NCT03894735` - Vitamin D in Ectopic Pregnancies
Recruiting	`NCT01860690` - BHCG Level in Day 4,7, in Comparison to Day 10 as an Indicator for Treatment Success	Phase 4
Recruiting	`NCT04176549` - Assessment of Biomarkers in Ectopic Pregnancy
Not yet recruiting	`NCT05890066` - Single-port Versus Multi-port Laparoscopic Surgery for Ectopic Pregnancy	N/A
Not yet recruiting	`NCT04308343` - The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy	N/A
Recruiting	`NCT06354439` - Use of Letrozole for Ectopic Pregnancy	Phase 4
Not yet recruiting	`NCT06300333` - Treatment of Ectopic Pregnancy by Low Dose of Methotrexate
Completed	`NCT00194272` - Two-Dose Methotrexate for Ectopic Pregnancy	Phase 3
Enrolling by invitation	`NCT03579550` - Hysteroscopic Metroplasty in Unexplained Infertile Women With Dysmorphic Uterus	N/A
Completed	`NCT05446012` - Relationship Between Ectopic Pregnancy and Thyroid Disorders
Completed	`NCT00194168` - Ectopic Pregnancy Biomarkers	N/A
Completed	`NCT02152696` - Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location	Phase 3
Not yet recruiting	`NCT04975984` - Expectant Management of Ectopic Pregnancy
Completed	`NCT04371991` - Kisspeptin Levels in Early Pregnancy

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.